| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Lipin_N | 6.42e-05 | 3 | 87 | 2 | IPR007651 | |
| Domain | Lipin_mid | 6.42e-05 | 3 | 87 | 2 | PF16876 | |
| Domain | Lipin_mid | 6.42e-05 | 3 | 87 | 2 | IPR031703 | |
| Domain | Lipin_N | 6.42e-05 | 3 | 87 | 2 | PF04571 | |
| Domain | RCC1 | 1.05e-04 | 20 | 87 | 3 | PF00415 | |
| Domain | RCC1_1 | 1.22e-04 | 21 | 87 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.22e-04 | 21 | 87 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.22e-04 | 21 | 87 | 3 | PS50012 | |
| Domain | Reg_chr_condens | 1.41e-04 | 22 | 87 | 3 | IPR000408 | |
| Domain | - | 1.41e-04 | 22 | 87 | 3 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 1.62e-04 | 23 | 87 | 3 | IPR009091 | |
| Domain | LNS2 | 3.18e-04 | 6 | 87 | 2 | PF08235 | |
| Domain | LNS2 | 3.18e-04 | 6 | 87 | 2 | IPR013209 | |
| Domain | LNS2 | 3.18e-04 | 6 | 87 | 2 | SM00775 | |
| Domain | LNS2/PITP | 3.18e-04 | 6 | 87 | 2 | IPR031315 | |
| Domain | Liprin | 3.18e-04 | 6 | 87 | 2 | IPR029515 | |
| Domain | VDCC_a1su_IQ | 4.44e-04 | 7 | 87 | 2 | IPR014873 | |
| Domain | GPHH | 4.44e-04 | 7 | 87 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.44e-04 | 7 | 87 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.44e-04 | 7 | 87 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 4.44e-04 | 7 | 87 | 2 | PF08763 | |
| Domain | VDCCAlpha1 | 9.42e-04 | 10 | 87 | 2 | IPR002077 | |
| Domain | - | 1.62e-03 | 13 | 87 | 2 | 2.10.10.10 | |
| Domain | MORN | 1.88e-03 | 14 | 87 | 2 | SM00698 | |
| Domain | FN_type2_col-bd | 1.88e-03 | 14 | 87 | 2 | IPR000562 | |
| Domain | FN2_2 | 1.88e-03 | 14 | 87 | 2 | PS51092 | |
| Domain | fn2 | 1.88e-03 | 14 | 87 | 2 | PF00040 | |
| Domain | FN2_1 | 1.88e-03 | 14 | 87 | 2 | PS00023 | |
| Domain | FN2 | 1.88e-03 | 14 | 87 | 2 | SM00059 | |
| Domain | MORN | 2.17e-03 | 15 | 87 | 2 | IPR003409 | |
| Domain | MORN | 2.17e-03 | 15 | 87 | 2 | PF02493 | |
| Domain | MAM | 2.79e-03 | 17 | 87 | 2 | SM00137 | |
| Domain | MAM | 3.13e-03 | 18 | 87 | 2 | PF00629 | |
| Domain | MAM_dom | 3.13e-03 | 18 | 87 | 2 | IPR000998 | |
| Domain | MAM_2 | 3.13e-03 | 18 | 87 | 2 | PS50060 | |
| Domain | - | 3.31e-03 | 64 | 87 | 3 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 5.98e-03 | 79 | 87 | 3 | IPR023214 | |
| Pubmed | 1.75e-06 | 34 | 89 | 4 | 26411367 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19717560 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15610184 | ||
| Pubmed | Increased smooth muscle contractility in mice deficient for neuropilin 2. | 6.48e-06 | 2 | 89 | 2 | 22688055 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22072677 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24133206 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 2722772 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22908270 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22573318 | ||
| Pubmed | Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. | 6.48e-06 | 2 | 89 | 2 | 38679985 | |
| Pubmed | Regulation of porcupine-dependent Wnt signaling is essential for uterine development and function. | 6.48e-06 | 2 | 89 | 2 | 29066530 | |
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 6.48e-06 | 2 | 89 | 2 | 12074836 | |
| Pubmed | Differential Roles of Lipin1 and Lipin2 in the Hepatitis C Virus Replication Cycle. | 6.48e-06 | 2 | 89 | 2 | 31752156 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 29534981 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN PLOD3 IGF2R MAN2B1 MAT2B FKTN MRC2 CD109 CPD EXTL2 NEK9 NRP2 COL1A1 | 1.15e-05 | 1201 | 89 | 13 | 35696571 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RRAS2 NIBAN1 PLOD3 IGF2R MAN2B1 AIFM1 MRC2 CD109 OSBPL11 CP CPD ADAMTS5 SEC23A NRP2 | 1.85e-05 | 1451 | 89 | 14 | 30550785 |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 10884287 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 30773264 | ||
| Pubmed | Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. | 1.94e-05 | 3 | 89 | 2 | 18694939 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 30507612 | ||
| Pubmed | Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. | 1.94e-05 | 3 | 89 | 2 | 33596934 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 20735359 | ||
| Pubmed | Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer. | 1.94e-05 | 3 | 89 | 2 | 26260940 | |
| Pubmed | Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. | 1.94e-05 | 3 | 89 | 2 | 22481384 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 19439667 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 21857965 | ||
| Pubmed | Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling. | 1.94e-05 | 3 | 89 | 2 | 25976672 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 24634820 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 38996073 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 20018910 | ||
| Pubmed | Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. | 1.94e-05 | 3 | 89 | 2 | 17158099 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.94e-05 | 3 | 89 | 2 | 24523520 | |
| Pubmed | 2.81e-05 | 613 | 89 | 9 | 22268729 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.95e-05 | 231 | 89 | 6 | 16452087 | |
| Pubmed | 3.41e-05 | 71 | 89 | 4 | 12754519 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.87e-05 | 4 | 89 | 2 | 32616470 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 26376991 | ||
| Pubmed | The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. | 3.87e-05 | 4 | 89 | 2 | 20418913 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 10829017 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 24019537 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19136718 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 3.87e-05 | 4 | 89 | 2 | 37141091 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 27965056 | ||
| Pubmed | Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. | 3.87e-05 | 4 | 89 | 2 | 19996109 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 11138012 | ||
| Pubmed | Mutations in the TBX15-ADAMTS2 pathway associate with a novel soft palate dysplasia. | 3.87e-05 | 4 | 89 | 2 | 36124393 | |
| Pubmed | Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. | 3.87e-05 | 4 | 89 | 2 | 25377472 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15647320 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 8825650 | ||
| Pubmed | A unique set of SH3-SH3 interactions controls IB1 homodimerization. | 6.44e-05 | 5 | 89 | 2 | 16456539 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 23906792 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15451373 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 11973338 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 27910070 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 19013515 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 11296258 | ||
| Pubmed | 7.58e-05 | 87 | 89 | 4 | 12465718 | ||
| Pubmed | BLM MTMR6 PLOD3 IGF2R AIFM1 PPFIA1 HELZ CPD FCHO2 MAPRE2 HELLS | 7.61e-05 | 1049 | 89 | 11 | 27880917 | |
| Pubmed | Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome. | 7.61e-05 | 32 | 89 | 3 | 36920550 | |
| Pubmed | 7.84e-05 | 170 | 89 | 5 | 15057823 | ||
| Pubmed | 9.44e-05 | 285 | 89 | 6 | 34369648 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 9.65e-05 | 6 | 89 | 2 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 9.65e-05 | 6 | 89 | 2 | 12827191 | |
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 9.65e-05 | 6 | 89 | 2 | 21618221 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 9238069 | ||
| Pubmed | SESTD1 MTMR6 IGF2R FEZ2 FBXW12 PPFIA1 DOCK9 OSBPL11 ATP11A ZNF318 FCHO2 | 1.02e-04 | 1084 | 89 | 11 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FZD7 PLOD3 IGF2R MAN2B1 DOCK9 MAP3K11 ATG2A TAGLN LYST MAPK8IP3 COL1A1 | 1.20e-04 | 1105 | 89 | 11 | 35748872 |
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 1.28e-04 | 38 | 89 | 3 | 16263699 | |
| Pubmed | Inhibition of polyamine synthesis causes entry of the mouse blastocyst into embryonic diapause. | 1.35e-04 | 7 | 89 | 2 | 28637295 | |
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 15448183 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.35e-04 | 7 | 89 | 2 | 35176221 | |
| Pubmed | Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. | 1.35e-04 | 7 | 89 | 2 | 12650714 | |
| Pubmed | Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. | 1.35e-04 | 7 | 89 | 2 | 12101239 | |
| Pubmed | Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. | 1.35e-04 | 7 | 89 | 2 | 11931740 | |
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 28330839 | ||
| Pubmed | 2.14e-04 | 472 | 89 | 7 | 38943005 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 16382099 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 12923177 | ||
| Pubmed | Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. | 2.30e-04 | 9 | 89 | 2 | 12629171 | |
| Pubmed | 2.72e-04 | 222 | 89 | 5 | 37071664 | ||
| Pubmed | 2.74e-04 | 347 | 89 | 6 | 17114649 | ||
| Pubmed | 2.88e-04 | 10 | 89 | 2 | 22687751 | ||
| Pubmed | Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. | 2.88e-04 | 10 | 89 | 2 | 11934855 | |
| Pubmed | Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. | 2.88e-04 | 10 | 89 | 2 | 10629060 | |
| Pubmed | Role of smooth muscle protein SM22α in glomerular epithelial cell injury. | 2.88e-04 | 10 | 89 | 2 | 21289056 | |
| Pubmed | Developmental dynamics of two bipotent thymic epithelial progenitor types. | 2.88e-04 | 10 | 89 | 2 | 35614226 | |
| Pubmed | 2.88e-04 | 10 | 89 | 2 | 18054859 | ||
| Pubmed | 3.09e-04 | 51 | 89 | 3 | 30478225 | ||
| Pubmed | 3.19e-04 | 504 | 89 | 7 | 34432599 | ||
| Pubmed | Vti1b promotes TRPV1 sensitization during inflammatory pain. | 3.26e-04 | 127 | 89 | 4 | 30335684 | |
| Pubmed | 3.40e-04 | 233 | 89 | 5 | 37704626 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 25978185 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 9427749 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 3.56e-04 | 130 | 89 | 4 | 35545047 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.85e-04 | 1061 | 89 | 10 | 33845483 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 4.20e-04 | 12 | 89 | 2 | 9624153 | |
| Pubmed | 4.20e-04 | 12 | 89 | 2 | 37935281 | ||
| Pubmed | 4.20e-04 | 12 | 89 | 2 | 20237151 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 4.25e-04 | 377 | 89 | 6 | 38117590 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.51e-04 | 248 | 89 | 5 | 24006456 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 9.10e-04 | 97 | 89 | 3 | chr14q21 | |
| GeneFamily | Lipins | 3.24e-05 | 3 | 60 | 2 | 1043 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 1.80e-05 | 160 | 89 | 6 | M338 | |
| Coexpression | GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP | 3.50e-05 | 180 | 89 | 6 | M2941 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP | 5.31e-05 | 194 | 89 | 6 | M4958 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | TBX15 FZD7 KCNT2 MRC2 OLFML2B ERRFI1 FGF7 CP TAGLN NRP2 COL1A1 | 5.75e-05 | 767 | 89 | 11 | M39209 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN | 5.95e-05 | 198 | 89 | 6 | M4424 | |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_DN | 6.29e-05 | 200 | 89 | 6 | M3386 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 6.29e-05 | 200 | 89 | 6 | M3508 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_DC_DN | 6.29e-05 | 200 | 89 | 6 | M4484 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 6.82e-05 | 519 | 89 | 9 | M3395 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | TBX15 OLFML2B ERRFI1 FGF7 CP CPD ADAMTS5 TAGLN HS3ST3A1 COL1A1 | 1.88e-05 | 455 | 88 | 10 | GSM777055_500 |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 189 | 89 | 7 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 189 | 89 | 7 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 189 | 89 | 7 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 189 | 89 | 7 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 189 | 89 | 7 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.10e-07 | 190 | 89 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-07 | 194 | 89 | 7 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-07 | 194 | 89 | 7 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-07 | 200 | 89 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-07 | 161 | 89 | 6 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-07 | 161 | 89 | 6 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 175 | 89 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-06 | 179 | 89 | 6 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 180 | 89 | 6 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 182 | 89 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 182 | 89 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 184 | 89 | 6 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 184 | 89 | 6 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-06 | 185 | 89 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 186 | 89 | 6 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 186 | 89 | 6 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.01e-06 | 186 | 89 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-06 | 186 | 89 | 6 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 187 | 89 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 187 | 89 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 187 | 89 | 6 | 51f1c6bac3abae1d20aa8ac46642bcdbc02cb0a2 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-06 | 187 | 89 | 6 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-06 | 187 | 89 | 6 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-06 | 188 | 89 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.28e-06 | 190 | 89 | 6 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-06 | 190 | 89 | 6 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-06 | 191 | 89 | 6 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 191 | 89 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-06 | 191 | 89 | 6 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 191 | 89 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-06 | 191 | 89 | 6 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-06 | 191 | 89 | 6 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 191 | 89 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 191 | 89 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-06 | 192 | 89 | 6 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | df56c3e3bb1aafc1126607f4426554c09c8c40cf | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-06 | 192 | 89 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 89 | 6 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-06 | 192 | 89 | 6 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-06 | 192 | 89 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.42e-06 | 192 | 89 | 6 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 193 | 89 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 193 | 89 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-06 | 193 | 89 | 6 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-06 | 193 | 89 | 6 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 193 | 89 | 6 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 193 | 89 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.57e-06 | 194 | 89 | 6 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 194 | 89 | 6 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-06 | 195 | 89 | 6 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-06 | 197 | 89 | 6 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 197 | 89 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 198 | 89 | 6 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 198 | 89 | 6 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.89e-06 | 198 | 89 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 198 | 89 | 6 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.47e-06 | 126 | 89 | 5 | 83f3540683b3b175b10af059ab8898c46eaccc13 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.47e-06 | 126 | 89 | 5 | 6d5075d659dac7b96e6857f8485a7d2c4105d685 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.47e-06 | 126 | 89 | 5 | fd0001a0f3a0a4421f96fd21813c21cf6f01d40e | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.47e-06 | 126 | 89 | 5 | f20424f9baf3c4059cd6b701761e7595400fc47c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-06 | 127 | 89 | 5 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 148 | 89 | 5 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.32e-05 | 151 | 89 | 5 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 154 | 89 | 5 | 9200e2f1783e54cbc5dfc3b485b57c761af74a46 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 154 | 89 | 5 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 156 | 89 | 5 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 162 | 89 | 5 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 164 | 89 | 5 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 168 | 89 | 5 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 172 | 89 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 172 | 89 | 5 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.61e-05 | 174 | 89 | 5 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; HL60; HT_HG-U133A | 1.07e-05 | 195 | 88 | 7 | 1270_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.11e-05 | 196 | 88 | 7 | 1338_DN | |
| Drug | aristolactam AII | 1.48e-05 | 2 | 88 | 2 | CID000148657 | |
| Drug | alkosin | 1.48e-05 | 2 | 88 | 2 | CID005488638 | |
| Drug | norcepharadione B | 1.48e-05 | 2 | 88 | 2 | CID000189168 | |
| Drug | piperolactam A | 1.48e-05 | 2 | 88 | 2 | CID003081016 | |
| Disease | myoglobinuria (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 5.14e-05 | 4 | 87 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | seasonality measurement, vitamin D measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0004631, EFO_0006876 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.79e-04 | 7 | 87 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | osteoarthritis (implicated_via_orthology) | 8.80e-04 | 15 | 87 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 8.80e-04 | 15 | 87 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | thyroid volume | 1.00e-03 | 16 | 87 | 2 | EFO_0004865 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 1.14e-03 | 17 | 87 | 2 | EFO_0008270 | |
| Disease | epilepsy (implicated_via_orthology) | 1.40e-03 | 163 | 87 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Parkinson Disease | 2.05e-03 | 85 | 87 | 3 | C0030567 | |
| Disease | antiphospholipid antibody measurement | 2.47e-03 | 25 | 87 | 2 | EFO_0005200 | |
| Disease | Ischemic stroke, coronary artery disease | 2.57e-03 | 92 | 87 | 3 | EFO_0001645, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WYMAVGTHRGKEAST | 111 | Q6UXC1 | |
| HKGSYLRNGWNVMDF | 151 | Q15878 | |
| GENMTGAAKPYWHQS | 466 | O95831 | |
| QEAGYSTHMVGKWHL | 136 | Q5FYB1 | |
| INGTVMNYSGWSHRD | 801 | Q9UNA0 | |
| WGEKNSGFDVLYHNM | 11 | Q0JRZ9 | |
| AEGEEMYLQGSSIWH | 246 | Q6H8Q1 | |
| FHKGSYLRNGWNVMD | 156 | Q00975 | |
| TGEDWNAVMYHGIES | 661 | Q00975 | |
| WLDYHGKHVTMDQVG | 1676 | Q2TAZ0 | |
| HTSAAKTQGGHVYMW | 296 | Q8NDN9 | |
| TSAAKTQGGHVYMWG | 321 | O95199 | |
| MDENEWGYHGEGNKS | 6 | Q9H8X2 | |
| NWYLMGMGNEIDLHT | 981 | P00450 | |
| YNNLMEHRWGSKGSR | 36 | Q9NRD9 | |
| IYEGQWEDNMRHGEG | 226 | P0C881 | |
| IYEGQWEDNMRHGEG | 226 | B2RC85 | |
| VAEMEHYGQWSGGRH | 581 | O60568 | |
| KHFTGGVMRWYQVEG | 216 | Q9NRZ9 | |
| MQKYHKSNGGIVWGN | 1061 | Q6P0N0 | |
| GTFHWSGNEQMTKYE | 246 | Q9NZL9 | |
| RGEDGQWDLSNYHLM | 1026 | Q9UPT6 | |
| YTWVNMQGGTKLHGQ | 391 | Q8TD19 | |
| ENGDGVIKSHMTYWR | 101 | Q8NI17 | |
| AEEYKRMGVPNSHWQ | 131 | Q9Y217 | |
| QTLAYGDMNHEWIGN | 936 | O75335 | |
| NIMWVVGGYMFNHSD | 351 | O75882 | |
| YDMHWVRQATGKGLE | 51 | P01766 | |
| SERSNGMKYEGEWAN | 296 | Q9HDC5 | |
| GMKYEGEWANNKRHG | 301 | Q9HDC5 | |
| NLEKETNSGYSGMWH | 271 | Q9UBQ6 | |
| RNGKWGGVEMHNKIY | 546 | P52789 | |
| TSENSVHVYMWEEGG | 396 | Q6X9E4 | |
| QYTWDMAKHGTDDGV | 451 | P02675 | |
| SMQRYHQDTQGWGDI | 431 | Q96PD5 | |
| AVYSSWMKEHGGSIV | 141 | Q9BY49 | |
| STNGEDWMVYRHGKN | 366 | O60462 | |
| DMTRGYLHWVNERGT | 731 | Q14693 | |
| TLAYGDMNHEWIGNE | 956 | Q13136 | |
| LSGDEVMYTHWNRDQ | 596 | Q9UBG0 | |
| NLKFYQMTGHDFGWD | 391 | Q9Y663 | |
| QGHGGDTWDYKSHVM | 226 | P59047 | |
| WMERQKSGGNYSRHR | 281 | Q6UVM3 | |
| EWIGGKMAQNGLDHY | 331 | P42694 | |
| DGRHIYMGSANMDWR | 221 | Q96BZ4 | |
| FGLGWRSYKHVSGQM | 761 | P06401 | |
| EEQGYGMAYTVHKWS | 426 | Q9H237 | |
| GMKWGHEAIEANSQY | 366 | O75084 | |
| YWSGSNSGNQKMEAV | 401 | Q6YHK3 | |
| SQWGHDFRQDYKRMN | 801 | P54132 | |
| TKHGWLYKGNMNSAI | 176 | Q9BZ29 | |
| VMWKHAKGSGNPQQY | 721 | Q8TD84 | |
| NGMKSDGTYWTIHIT | 231 | P17707 | |
| SYDSVRRGAWGNNMN | 221 | Q01543 | |
| ITNGAHWYDVEGGMQ | 321 | O75976 | |
| YEETDHMWNGGTQAK | 371 | O75072 | |
| GMYKVDLSASRHWQE | 2911 | Q99698 | |
| EFKYQMTRTGWHATE | 146 | Q9UI17 | |
| KHTVRGERSYSWGMA | 31 | Q15555 | |
| ANGGWVMNDEAATHY | 151 | O00754 | |
| NGAGMSYEAKHVWEC | 281 | Q9UQ10 | |
| GRHMFVWGGYKSNQV | 41 | Q9Y2U9 | |
| YASAKWTHNGGEMFV | 151 | P21781 | |
| SFHSMQEGWKREIQG | 391 | Q16584 | |
| WYHNGKEMQGRTEEK | 366 | P20273 | |
| DNYGNVMPVDWKSSH | 96 | Q9UHY8 | |
| GGSAKGWQYSDHMEN | 46 | Q9BXB4 | |
| EHIMETGWKNRSVGY | 186 | Q9P2E2 | |
| AMDNSGEHVTWRKYY | 796 | P11717 | |
| HRMNDDWAYGNDIDA | 741 | Q9ULQ0 | |
| VYHSSKWMVAGNADS | 176 | Q96SF7 | |
| DGKDKSSANWMRYVN | 306 | Q9NQW5 | |
| MAAAGWRDGSGQEKY | 1 | P62070 | |
| NDGHYRGDPNWFMKK | 141 | Q01995 | |
| TQNTYGRNEGAWMKD | 506 | Q68BL8 | |
| HNGRAMGNMRKTYWS | 21 | Q9UJM3 | |
| GETIAQWRKSGYQDM | 661 | Q15436 | |
| GGSLTYDHMDWLNKR | 146 | Q86VW0 | |
| KRHVWFGESMTDGFQ | 1321 | P02452 | |
| QGYEDWLRHKADNAM | 111 | P98196 | |
| NAGAEENYHRNMSWL | 1446 | Q8N2C7 | |
| HEMATYFWAMGQEGV | 531 | Q9NZQ8 | |
| RQEKGHYGSWEMITG | 221 | Q9BZQ8 | |
| MNDKLGYGSWFEHVQ | 166 | Q9BR01 | |
| GSEHMYQFTVLGQRW | 421 | Q6UWL2 | |
| NVYDQAWRGGKDMAQ | 431 | Q13573 | |
| MLTADHGGYVKYWQS | 176 | Q9C0J8 | |
| DKGQNWGHMGLHYSV | 341 | Q6PP77 | |
| IDDSNLNHGNRYMWE | 1806 | Q5VUA4 | |
| LNHGNRYMWEGEVKQ | 1811 | Q5VUA4 | |
| ADMTRGYLHWVNDKG | 741 | Q92539 | |
| TTGYGIAMQKDSHWK | 756 | Q14957 |